Topical furosemide versus oral steroid in preoperative management of nasal polyposis
- PMID:16685542
- DOI: 10.1007/s00405-006-0061-7
Topical furosemide versus oral steroid in preoperative management of nasal polyposis
Abstract
The efficacy of topical nasal furosemide treatment has been shown in the protection of nasal polyp recurrence. The aim of the study was to compare the effect of oral steroid, as standard preoperative treatment, and inhaled furosemide, as alternative treatment, for 7 days preoperatively in terms of subjective improvement of nasal symptoms, polyp size reduction, inflammation in the polyp tissue, and intraoperative blood loss. A group of 40 patients with nasal polyposis entered the study and they were randomly allocated to 7-day preoperative treatment with either oral methylprednisolon (1 mg/kg/day) or topical furosemide by inhalation (6.6 mmol/l solution). Subjective scores of rhinosinusitis symptoms, polyp scores at endoscopy, and biopsy of the most superficial polyp were taken at inclusion. All procedures were repeated on day 7. Intraoperative blood loss was estimated (scores 0-10) by the surgeon at the operation. Eosinophils, mastocytes, and oedema were quantified by histomorphometry. Subjective symptoms and endoscopy scores did not differ significantly between the groups after the treatment although improvement of olfaction was insignificantly better in the steroid group. Steroid treatment significantly reduced eosinophil count, with no effect on mastocytes and oedema. Furosemide treatment did not affect inflammatory cells count significantly, but it has significantly reduced oedema in previously unoperated patients. No difference in intraoperative bleeding was observed between the groups.
Similar articles
- Efficacy of systemic steroid treatment in sinonasal polyposis.Berkiten G, Salturk Z, Topaloğlu I.Berkiten G, et al.J Craniofac Surg. 2013 May;24(3):e305-8. doi: 10.1097/SCS.0b013e31828f261f.J Craniofac Surg. 2013.PMID:23715001
- Effect of Topical Furosemide on Rhinosinusal Polyposis Relapse After Endoscopic Sinus Surgery: A Randomized Clinical Trial.Hashemian F, Ghorbanian MA, Hashemian F, Mortazavi SA, Sheikhi M, Jahanshahi J, Poorolajal J.Hashemian F, et al.JAMA Otolaryngol Head Neck Surg. 2016 Nov 1;142(11):1045-1049. doi: 10.1001/jamaoto.2016.1249.JAMA Otolaryngol Head Neck Surg. 2016.PMID:27416546Clinical Trial.
- The effectiveness of steroid treatment in nasal polyposis.Tuncer U, Soylu L, Aydogan B, Karakus F, Akcali C.Tuncer U, et al.Auris Nasus Larynx. 2003 Aug;30(3):263-8. doi: 10.1016/s0385-8146(03)00051-8.Auris Nasus Larynx. 2003.PMID:12927289Clinical Trial.
- Topical steroids for nasal polyps.Kalish L, Snidvongs K, Sivasubramaniam R, Cope D, Harvey RJ.Kalish L, et al.Cochrane Database Syst Rev. 2012 Dec 12;12:CD006549. doi: 10.1002/14651858.CD006549.pub2.Cochrane Database Syst Rev. 2012.Update in:Cochrane Database Syst Rev. 2016 Apr 25;4:CD006549. doi: 10.1002/14651858.CD006549.pub3.PMID:23235631Updated.Review.
- Olfactory outcomes in chronic rhinosinusitis with nasal polyposis after medical treatments: a systematic review and meta-analysis.Banglawala SM, Oyer SL, Lohia S, Psaltis AJ, Soler ZM, Schlosser RJ.Banglawala SM, et al.Int Forum Allergy Rhinol. 2014 Dec;4(12):986-94. doi: 10.1002/alr.21373. Epub 2014 Nov 14.Int Forum Allergy Rhinol. 2014.PMID:25400017Review.
Cited by
- Effect of Topical Furosemide Efficacy on Reducing Bleeding and Quality of Surgical Field During Endoscopic Sinus Surgery in Patients with Chronic Rhinosinusitis.Jahanshahi J, Ghorbani M, Hashemian F, Hashemian F, Sheikhi M, Khanlarzadeh E.Jahanshahi J, et al.Iran J Otorhinolaryngol. 2022 Sep;34(124):219-224. doi: 10.22038/IJORL.2022.57445.2973.Iran J Otorhinolaryngol. 2022.PMID:36246196Free PMC article.
- Update on the management of chronic rhinosinusitis.Cain RB, Lal D.Cain RB, et al.Infect Drug Resist. 2013;6:1-14. doi: 10.2147/IDR.S26134. Epub 2013 Jan 23.Infect Drug Resist. 2013.PMID:23378777Free PMC article.
- Chronic rhinosinusitis and emerging treatment options.Piromchai P, Kasemsiri P, Laohasiriwong S, Thanaviratananich S.Piromchai P, et al.Int J Gen Med. 2013 Jun 7;6:453-64. doi: 10.2147/IJGM.S29977. Print 2013.Int J Gen Med. 2013.PMID:23785241Free PMC article.
- Short-course oral steroids alone for chronic rhinosinusitis.Head K, Chong LY, Hopkins C, Philpott C, Burton MJ, Schilder AG.Head K, et al.Cochrane Database Syst Rev. 2016 Apr 26;4(4):CD011991. doi: 10.1002/14651858.CD011991.pub2.Cochrane Database Syst Rev. 2016.PMID:27113367Free PMC article.Review.
- Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis.Head K, Chong LY, Hopkins C, Philpott C, Schilder AG, Burton MJ.Head K, et al.Cochrane Database Syst Rev. 2016 Apr 26;4(4):CD011992. doi: 10.1002/14651858.CD011992.pub2.Cochrane Database Syst Rev. 2016.PMID:27115214Free PMC article.Review.
References
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical